The DECIDE trial: prospective, multi-center, randomized study to evaluate the CoStar paclitaxel-eluting coronary stent system using a direct stenting technique compared to conventional stenting with pre-dilatation strategy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Paclitaxel (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms DECIDE
- 30 Oct 2009 Biomarkers information updated
- 16 Oct 2008 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 16 Oct 2008 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.